HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report.

Abstract
Low-dose interferon-α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high-risk polycythemia vera patients.
AuthorsChristoph Driessen, Christoph Noppen, Georg Boonen, Juergen Drewe
JournalClinical case reports (Clin Case Rep) Vol. 9 Issue 10 Pg. e04903 (Oct 2021) ISSN: 2050-0904 [Print] England
PMID34631086 (Publication Type: Case Reports)
Copyright© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: